Hong Kong stock's innovative pharmaceutical sector continued to rise in the afternoon, with Rongchang Biology up nearly 10%.

In the afternoon, the Hong Kong stock innovative pharmaceutical sector continued to rise, with Rongchang Biology up nearly 10%, Junshi Biology up over 5%, and Nuo Cheng Jianhua, Xinda Biology, and Fosun Pharmaceuticals following suit.